SARcode Biosciences' Acquisition

SARcode Biosciences was acquired by Shire on March 25, 2013.

SARcode is a private, San Francisco based biotechnology company focused on the development of small molecule LFA-1 antagonists to treat inflammatory diseases. Targets include topical therapies for T-c…

Articles about SARcode Biosciences' Acquisition: